The Early Jurassic Toarcian Oceanic Anoxic Event (T-OAE) with its associated carbon-isotope excursion (CIE) was possibly one of the most pronounced periods of widespread oxygen deficiency in the Mesozoic ocean. The event has been extensively studied in order to understand the processes triggering the environmental perturbations and the extreme oxygen depletion in many marine basins. However, comparatively little focus has been placed on the end of the positive CIE and the stratigraphic coherent end of anoxiceuxinic conditions. In the present study, we constrain the stratigraphic extent of anoxic-euxinic conditions and define the termination of the positive CIE in the Swabo-Franconian Basin covering the Lower Toarcian strata using carbon-isotope ratios, organic matter pyrolysis and redox-sensitive element concentrations of outcrop samples from the Aubach section. Bulk organic carbon-isotope values, corrected for changes in type of organic matter using the Hydrogen Index (HI), suggest that the amplitude of the negative CIE in organic matter is as little as 3.3-3.5 ‰, in contrast to 4.5 ‰ change in δ 13 C carb in the same section. Enrichment in redox-sensitive proxies (V/Al and DOP-T) and %TOC suggest that environmental perturbations associated with the T-OAE continued until the upper falciferum Zone in the Aubach section. This indicates that anoxic-euxinic conditions terminated in the same stratigraphic interval in which δ 13 C values return to steady, light values at ~-28 ‰ (termination of positive CIE). This synchronism in the return to normal marine conditions is also observed in the southern Paris Basin, but not in the Cleveland Basin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.